Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE These results suggest that the Val allele of CYP1A1 Ile462Val polymorphism and the Pro allele of TP53 Arg72Pro polymorphism contribute to an increased risk of GBC among Japanese women and men, respectively. 17531965 2007
Entrez Id: 1543
Gene Symbol: CYP1A1
CYP1A1
0.080 GeneticVariation disease BEFREE These results suggest that the Val allele of CYP1A1 Ile462Val polymorphism and the Pro allele of TP53 Arg72Pro polymorphism contribute to an increased risk of GBC among Japanese women and men, respectively. 17531965 2007
Entrez Id: 2944
Gene Symbol: GSTM1
GSTM1
0.040 Biomarker disease BEFREE To examine the relationship between genetic polymorphisms of cytochrome P450 1A1 (CYP1A1), glutathione S-transferase class mu (GSTM1), and tumour protein p53 (TP53) genes, and gallbladder cancer (GBC) risk, a case-control study was conducted. 17531965 2007
Entrez Id: 4968
Gene Symbol: OGG1
OGG1
0.040 GeneticVariation disease BEFREE These data corresponded with the fact that a significant trend towards increased association for gallbladder cancer was observed with potentially higher-risk hOGG1 genotypes in gallstone presence(p < 0.001, chi(2) trend test)but not in gallstone absence(p = 0.89, chi(2) trend test). 17417784 2007
Entrez Id: 338
Gene Symbol: APOB
APOB
0.030 PosttranslationalModification disease BEFREE Haplotype analysis of signal peptide (insertion/deletion) and XbaI polymorphisms of the APOB gene in gallbladder cancer. 17696941 2007
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.020 PosttranslationalModification disease BEFREE Homozygous deletion, a combination of LOH and promoter hypermethylation, and multiple LOH are major mechanisms of p16 inactivation in gallbladder cancer. 18081229 2007
Entrez Id: 27306
Gene Symbol: HPGDS
HPGDS
0.020 GeneticVariation disease BEFREE Polymorphisms of cytochrome P450 1A1, glutathione S-transferase class mu, and tumour protein p53 genes and the risk of developing gallbladder cancer in Japanese. 17531965 2007
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.020 PosttranslationalModification disease BEFREE Homozygous deletion, a combination of LOH and promoter hypermethylation, and multiple LOH are major mechanisms of p16 inactivation in gallbladder cancer. 18081229 2007
Entrez Id: 1028
Gene Symbol: CDKN1C
CDKN1C
0.010 Biomarker disease BEFREE Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer. 17595796 2007
Entrez Id: 10518
Gene Symbol: CIB2
CIB2
0.010 Biomarker disease BEFREE Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer. 17595796 2007
Entrez Id: 1026
Gene Symbol: CDKN1A
CDKN1A
0.010 Biomarker disease BEFREE Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer. 17595796 2007
Entrez Id: 10
Gene Symbol: NAT2
NAT2
0.010 GeneticVariation disease BEFREE Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone disease. 17224641 2007
Entrez Id: 56996
Gene Symbol: SLC12A9
SLC12A9
0.010 Biomarker disease BEFREE Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer. 17595796 2007
Entrez Id: 11186
Gene Symbol: RASSF1
RASSF1
0.010 GeneticVariation disease BEFREE Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer. 18182852 2007
Entrez Id: 4292
Gene Symbol: MLH1
MLH1
0.010 AlteredExpression disease BEFREE SiRNA double strand RNA (dsRNA) was transiently transfected into KMG-C (gallbladder cancer) cells. hMLH1 mRNA expression was repressed by hMLH1 dsRNA in a dose-dependent manner in comparison to the control dsRNA. 17465213 2007
Entrez Id: 1543
Gene Symbol: CYP1A1
CYP1A1
0.080 GeneticVariation disease BEFREE The CYP1A1 C allele frequency was also higher in GBC patients (OR 1.4, 95% CI=1.0-2.0, P=0.039). 18287863 2008
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.080 GeneticVariation disease BEFREE Specifically, variants in the IL8, IL8RB, RNASEL, and NOS2 genes were associated with biliary stones, whereas VEGF variants were associated with gallbladder cancer. 18676870 2008
Entrez Id: 885
Gene Symbol: CCK
CCK
0.050 GeneticVariation disease BEFREE Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer. 17944886 2008
Entrez Id: 9817
Gene Symbol: KEAP1
KEAP1
0.020 GeneticVariation disease BEFREE Keap1 mutation occurs frequently in GBC. 18692501 2008
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.020 Biomarker disease BEFREE Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. 18692501 2008
Entrez Id: 1581
Gene Symbol: CYP7A1
CYP7A1
0.020 GeneticVariation disease BEFREE Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer. 18178499 2008
Entrez Id: 1490
Gene Symbol: CCN2
CCN2
0.020 Biomarker disease BEFREE By immunohistochemistry, 66 of 182 (36%) GBC had high CTGF antigen labeling, which was significantly associated with better survival on univariate analysis (P = 0.0069, log-rank test). 18451226 2008
Entrez Id: 2551
Gene Symbol: GABPA
GABPA
0.020 Biomarker disease BEFREE Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. 18692501 2008
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.020 GeneticVariation disease BEFREE The TGFB1-509C>T polymorphism was not associated with GBC. 18571008 2008
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.010 GeneticVariation disease BEFREE No association of Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in susceptibility to gallbladder cancer. 17979520 2008